Health • May 18, 2026

New pancreatic cancer pill could reshape treatment as early trial results stun researchers

Originally published on Fox News Health

New pancreatic cancer pill could reshape treatment as early trial results stun researchers

A new daily pill called daraxonrasib is showing promise against advanced pancreatic cancer in a first-in-human trial of 168 patients with RAS mutations.

A new daily pill called daraxonrasib is showing promise against advanced pancreatic cancer in a first-in-human trial of 168 patients with RAS mutations.
Originally published on Fox News Health.
Have a story like this? Submit it here →

More good news